What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Surgery
Christopher G. Wood mainly focuses on Renal cell carcinoma, Surgery, Carcinoma, Internal medicine and Cancer.
His research integrates issues of Targeted therapy and Kidney disease in his study of Renal cell carcinoma.
His Surgery study integrates concerns from other disciplines, such as Lymphovascular invasion and Nephrectomy.
Christopher G. Wood combines subjects such as Urology, Transitional cell carcinoma, Immunology, Metastasis and Single-nucleotide polymorphism with his study of Carcinoma.
His Internal medicine research includes elements of Endocrinology and Oncology.
Christopher G. Wood interconnects RNA, Transcription factor, Kidney metabolism and Downregulation and upregulation in the investigation of issues within Cancer.
His most cited work include:
- Comprehensivemolecular characterization of clear cell renal cell carcinoma (1909 citations)
- Outcomes of radical nephroureterectomy: A series from the Upper Tract Urothelial Carcinoma Collaboration (658 citations)
- Prognostic Value of Histologic Subtypes in Renal Cell Carcinoma: A Multicenter Experience (555 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Renal cell carcinoma, Internal medicine, Oncology, Surgery and Nephrectomy.
His Renal cell carcinoma research integrates issues from Cancer, Carcinoma and Urology.
His work on Nephrology, Targeted therapy, Stage and Sunitinib as part of general Internal medicine study is frequently linked to In patient, therefore connecting diverse disciplines of science.
His work carried out in the field of Oncology brings together such families of science as Upper tract, Primary tumor, Proportional hazards model and Cohort.
His Surgery study incorporates themes from Radiology and Kidney disease.
His Nephrectomy study combines topics in areas such as Survival rate, Performance status and Hazard ratio.
He most often published in these fields:
- Renal cell carcinoma (51.12%)
- Internal medicine (44.23%)
- Oncology (33.73%)
What were the highlights of his more recent work (between 2017-2021)?
- Renal cell carcinoma (51.12%)
- Internal medicine (44.23%)
- Oncology (33.73%)
In recent papers he was focusing on the following fields of study:
Christopher G. Wood focuses on Renal cell carcinoma, Internal medicine, Oncology, Nephrectomy and Urology.
His study in Renal cell carcinoma is interdisciplinary in nature, drawing from both Cancer, Confidence interval, Carcinoma, Radiology and Cohort.
His Carcinoma research is multidisciplinary, relying on both Kidney and Gene expression profiling.
His work on Clear cell renal cell carcinoma, Sunitinib and Overall survival as part of his general Oncology study is frequently connected to In patient, thereby bridging the divide between different branches of science.
His work deals with themes such as Surgery, Positive Surgical Margin and Hazard ratio, which intersect with Nephrectomy.
His Urology research is multidisciplinary, incorporating elements of Upper tract and Proportional hazards model.
Between 2017 and 2021, his most popular works were:
- Epidemiology of Renal Cell Carcinoma. (237 citations)
- Systemic Treatment of Metastatic Clear Cell Renal Cell Carcinoma in 2018: Current Paradigms, Use of Immunotherapy, and Future Directions. (69 citations)
- The society for immunotherapy of cancer consensus statement on immunotherapy for the treatment of advanced renal cell carcinoma (RCC). (49 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Gene
The scientist’s investigation covers issues in Renal cell carcinoma, Internal medicine, Oncology, Nephrectomy and Urology.
The various areas that Christopher G. Wood examines in his Renal cell carcinoma study include Adjuvant, Carcinoma, Incidence and Metastasectomy.
His research in Carcinoma intersects with topics in Kidney and Gene expression profiling.
His work carried out in the field of Incidence brings together such families of science as Mortality rate, Surgery and Kidney disease.
He is involved in the study of Oncology that focuses on Clear cell renal cell carcinoma in particular.
His Nephrectomy study combines topics from a wide range of disciplines, such as Cancer, Multivariate analysis, Surgical planning, Radiology and Hazard ratio.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
